Challenges in containing the burden of hepatitis B infection in dialysis and transplant patients in India

Nephrology

Volumn 16, Issue 4, 2011, Pages 383-388

  Potsangbam, Guliver ^a   Yadav, Ashok ^a   Chandel, Nirupama ^a   Rathi, Manish ^a   Sharma, Ashish ^a   Kohli, Harbir S ^a   Gupta, Krishan L ^a   Minz, Mukut ^a   Sakhuja, Vinay ^a   Jha, Vivekanand ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

end stage renal disease; hepatitis B; occult infection; vaccination

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DRUG EFFICACY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; INDIA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SEROLOGY; VACCINATION; VIREMIA;

ADULT; BIOLOGICAL MARKERS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION SCHEDULE; INDIA; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME; VACCINATION; VIRAL LOAD; YOUNG ADULT;

EID: 79955416246     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2010.01429.x     Document Type: Article

References (35)

1. Wing AJ, Brunner FP, Brynger H, et al,. Combined report on regular dialysis and transplantation in Europe, VIII, 1977. Proc. Eur. Dial. Transplant Assoc. 1978; 15: 2-76.
2. Crosnier J, Jungers P, Courouce AM, et al,. Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet 1981; 1: 797-800. (Pubitemid 11147433)
3. Ocama P, Opio CK, Lee WM,. Hepatitis B virus infection: Current status. Am. J. Med. 2005; 118: 1413.
4. Verma A, Wade JJ,. Immunization issues before and after solid organ transplantation in children. Pediatr. Transplant. 2006; 10: 536-48.
5. Avery RK,. Immunizations in adult immunocompromised patients: Which to use and which to avoid. Cleve. Clin. J. Med. 2001; 68: 337-48. (Pubitemid 32303602)
6. Center for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm. Rep. 2001; 50: 1-43.
7. Avery RK, Ljungman P,. Prophylactic measures in the solid-organ recipient before transplantation. Clin. Infect. Dis. 2001; 33 (Suppl 1): S15-21. (Pubitemid 32554481)
8. Duchini A, Goss JA, Karpen S, Pockros PJ,. Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin. Microbiol. Rev. 2003; 16: 357-64. (Pubitemid 36871311)
9. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Flik J,. Failure of vaccination against hepatitis B with Gen H-B-Vax-D in immunosuppressed heart transplant recipients. Clin. Investig. 1992; 70: 585-7.
10. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Thoma HA, Hemmerling AE, Flik J,. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa Gene 3 containing pre-S1, pre-S2, and S gene products. Clin. Investig. 1994; 72: 350-2. (Pubitemid 24171920)
11. Jha V,. Current status of chronic kidney disease care in southeast Asia. Semin. Nephrol. 2009; 29: 487-96.
12. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P,. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial. Int. 2005; 9: 362-6. (Pubitemid 41614647)
13. Reddy GA, Dakshinamurthy KV, Neelaprasad P, Gangadhar T, Lakshmi V,. Prevalence of HBV and HCV dual infection in patients on haemodialysis. Indian J. Med. Microbiol. 2005; 23: 41-3. (Pubitemid 40347433)
14. Molrine DC, Hibberd PL,. Vaccines for transplant recipients. Infect. Dis. Clin. North Am. 2001; 15: 273-305. (Pubitemid 32268125)
15. Rambusch EG, Nashan B, Tillmann HL, et al,. [De novo hepatitis B infection after liver transplantation-evidence for the need of active hepatitis B vaccination of liver transplantation candidates]. Z. Gastroenterol. 1998; 36: 1027-35. (Pubitemid 29021976)
16. Rosenau J, Hooman N, Hadem J, et al,. Failure of hepatitis B vaccination with conventional HBsAg vaccine in patients with continuous HBIG prophylaxis after liver transplantation. Liver Transpl. 2007; 13: 367-73. (Pubitemid 46444465)
17. Fabrizi F, Marzano A, Messa P, Martin P, Lampertico P,. Hepatitis B virus infection in the dialysis population: Current perspectives. Int. J. Artif. Organs 2008; 31: 386-94. (Pubitemid 351983351)
18. Minuk GY, Sun DF, Greenberg R, et al,. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004; 40: 1072-7. (Pubitemid 39425562)
19. Chandra M, Khaja MN, Hussain MM, et al,. Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure. Intervirology 2004; 47: 374-6. (Pubitemid 39541285)
20. Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity. Lancet 2000; 355: 561-5.
21. Feuerhake A, Muller R, Lauchart W, Pichlmayr R, Schmidt FW,. HBV-vaccination in recipients of kidney allografts. Vaccine 1984; 2: 255-6. (Pubitemid 15172281)
22. Grob PJ, Binswanger U, Zaruba K, et al,. Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients. Antiviral Res. 1983; 3: 43-52. (Pubitemid 13105967)
23. Jacobson IM, Jaffers G, Dienstag JL, et al,. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 1985; 39: 393-5. (Pubitemid 15107839)
24. Grob P,. Hepatitis B vaccination of renal transplant and hemodialysis patients. Scand. J. Infect. Dis. Suppl. 1983; 38: 28-32. (Pubitemid 14246312)
25. Barclay S, Pol S, Mutimer D, et al,. Erratum to 'The management of chronic hepatitis B in the immunocompromised patient: Recommendations from a single topic meeting'[J. Clin. Virol. 41 (4) 2008 243-254]. J. Clin. Virol. 2008; 42: 104-15.
26. Jha V, Chugh KS,. The practice of dialysis in the developing countries. Hemodial. Int. 2003; 7: 239-49.
27. Jha V, Chugh KS,. Posttransplant infections in the tropical countries. Artif. Organs 2002; 26: 770-7. (Pubitemid 35013762)
28. Di Stefano M, Volpe A, Stallone G, et al,. Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV. J. Nephrol. 2009; 22: 381-6.
29. Peres AA, Dias EA, Chesky M, et al,. Occult hepatitis B in renal transplant patients. Transpl. Infect. Dis. 2005; 7: 51-6. (Pubitemid 41341360)
30. Fabrizi F, Messa PG, Lunghi G, et al,. Occult hepatitis B virus infection in dialysis patients: A multicentre survey. Aliment. Pharmacol. Ther. 2005; 21: 1341-7. (Pubitemid 40813680)
31. Jardim RN, Goncales NS, Pereira JS, Fais VC, Goncales Junior FL,. Occult hepatitis B virus infection in immunocompromised patients. Braz. J. Infect. Dis. 2008; 12: 300-5.
32. Kim KH, Ahn SH, Chung HY, et al,. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity. J. Gastroenterol. Hepatol. 2004; 19: 847-53.
33. Sobhonslidsuk A, Sornmayura P, Sumethkul V,. Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient. J. Med. Assoc. Thai. 2006; 89 (Suppl 2): S257-61. (Pubitemid 44903893)
34. Besisik F, Karaca C, Akyuz F, et al,. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J. Hepatol. 2003; 38: 506-10. (Pubitemid 36399255)
35. Kasiske BL, Zeier MG, Chapman JR, et al,. KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int. 2009; 77: 299-311.